COVID-19 vax lowers severity, mortality post infection

COVID-19 vax lowers severity, mortality post infection

In one of the largest studies of its kind, researchers provide answers to whether COVID-19 vaccinations reduce sickness and mortality following infection with SARS-CoV-2. The study published in The Lancet Microbe found among individuals recently infected with...
Study finds new way to stop excess COVID inflammation

Study finds new way to stop excess COVID inflammation

By Maria Fernanda Ziegler  |  Agência FAPESP – Researchers at the University of São Paulo (USP) in Brazil have identified a new class of molecules capable of stopping the excessive inflammation typical of the severe form of COVID-19 without impairing the immune...
HHS advisory on long-COVID mental health conditions

HHS advisory on long-COVID mental health conditions

The U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), issued a new advisory: Identification and Management of Mental Health Symptoms and Conditions Associated with Long COVID. “Long...
WHO advisers recommend switch to monovalent COVID vax

WHO advisers recommend switch to monovalent COVID vax

The World Health Organization (WHO) COVID vaccine composition advisory group met to discuss the latest SARS-CoV-2 changes and impacts on the vaccine and recommended that vaccine makers drop the ancestral strain and switch to a monovalent (single-strain) vaccine that...
COVID Drug Candidate Could Reduce Infection Length

COVID Drug Candidate Could Reduce Infection Length

The discovery of a small molecule in the research lab of Bradley McConnell, professor of pharmacology at the University of Houston College of Pharmacy, may well be the genesis of new medication which could shorten the course of the SARS-CoV-2 virus. Unlike Pfizer’s...